- Home
- DSGN vs NWFL Comparison
DSGN vs NWFL Comparison
Compare DSGN & NWFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- DSGN
- NWFL
- Stock Information
- Founded
- DSGN 2017
- NWFL 1870
- Country
- DSGN United States
- NWFL United States
- Employees
- DSGN N/A
- NWFL N/A
- Industry
- DSGN Biotechnology: Pharmaceutical Preparations
- NWFL Major Banks
- Sector
- DSGN Health Care
- NWFL Finance
- Exchange
- DSGN Nasdaq
- NWFL Nasdaq
- Market Cap
- DSGN 264.4M
- NWFL 249.5M
- IPO Year
- DSGN 2021
- NWFL 1998
- Fundamental
- Price
- DSGN $5.57
- NWFL $29.83
- Analyst Decision
- DSGN Hold
- NWFL
- Analyst Count
- DSGN 3
- NWFL 0
- Target Price
- DSGN $7.00
- NWFL N/A
- AVG Volume (30 Days)
- DSGN 142.1K
- NWFL 9.1K
- Earning Date
- DSGN 11-07-2024
- NWFL 10-28-2024
- Dividend Yield
- DSGN N/A
- NWFL 4.11%
- EPS Growth
- DSGN N/A
- NWFL N/A
- EPS
- DSGN N/A
- NWFL 1.59
- Revenue
- DSGN N/A
- NWFL $62,305,000.00
- Revenue This Year
- DSGN N/A
- NWFL N/A
- Revenue Next Year
- DSGN N/A
- NWFL N/A
- P/E Ratio
- DSGN N/A
- NWFL $18.39
- Revenue Growth
- DSGN N/A
- NWFL N/A
- 52 Week Low
- DSGN $2.13
- NWFL $23.50
- 52 Week High
- DSGN $7.77
- NWFL $34.50
- Technical
- Relative Strength Index (RSI)
- DSGN 47.80
- NWFL 50.30
- Support Level
- DSGN $5.32
- NWFL $29.23
- Resistance Level
- DSGN $7.77
- NWFL $31.40
- Average True Range (ATR)
- DSGN 0.58
- NWFL 1.06
- MACD
- DSGN -0.09
- NWFL -0.25
- Stochastic Oscillator
- DSGN 19.12
- NWFL 22.68
About DSGN Design Therapeutics Inc.
Design Therapeutics Inc is a clinical-stage biopharmaceutical company engaged in the research and development of GeneTACTM molecules, which are a novel class of small-molecule gene-targeted chimera therapeutic candidates designed to be disease-modifying by addressing the underlying cause of diseases caused by inherited nucleotide repeat expansion mutations. The Company's product candidate is in Friedreich ataxia (FA), its second product candidate is in Fuchs endothelial corneal dystrophy (FECD), and it is also advancing its GeneTACTM program to address other serious nucleotide repeat-driven monogenic diseases.
About NWFL Norwood Financial Corp.
Norwood Financial Corp is a U.S.-based bank holding company. It offers various personal and business credit services, trust and investment products, and real estate settlement services to consumers, businesses, nonprofit organizations, and municipalities in each of the communities that the bank serves. The bank also manages automated teller machines at its branch location. It serves the Pennsylvanian counties of Wayne, Pike, Monroe, and Lackawanna, as well as Susquehanna County.